.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Jesper Velgaard Olsen

Copenhagen / DK

University of Copenhagen

Weitere Beteiligungen

Mo., 21.10.
11:32 – 11:44 10 Min. 2 Min.
Oral presentation
OP-05
Multiomics characterization of in vivo resistance to anti-VEGF therapy in ovarian carcinoma
Multiomics Approaches
Mo., 21.10.
Poster presentation
P-I-0346
Acrivon Predictive Precision Proteomics (AP3)-guided development and prospective clinical Phase 2 validation of the response-predictive OncoSignature test for the CHK1/2 inhibitor, ACR-368
Clinical Proteomics
Mo., 21.10.
Poster presentation
P-I-0025
Accelerating single-shot phosphoproteomics by identification and quantitation of > 100,000 phosphosites in human cell lines
Defining Signaling Networks - Functional PTMs
Mo., 21.10.
Poster presentation
P-I-0123
Ion mobility free high throughput peptide collisional cross-section measurements in fourier transform mass spectrometer on the proteome wide scale
New Technology: MS-based Proteomics
Di., 22.10.
11:17 – 11:29 10 Min. 2 Min.
Oral presentation
OP-35
Global analysis of protein turnover dynamics in single cells during stem cell differentiation
New Technology: MS-based Proteomics
Di., 22.10.
11:17 – 11:29 10 Min. 2 Min.
Oral presentation
OP-41
Proteomics of neuroinflammatory signalling: illuminating cellular mechanisms driving neurodegenerative diseases
Defining Signaling Networks - Functional PTMs
Di., 22.10.
Poster presentation
P-II-0478
Statistical benchmark of Label-free DIA quantification using the generic integration algorithm with iSanXoT
New Technology: AI and Bioinformatics in Mass Spectrometry
Di., 22.10.
Poster presentation
P-II-0406
Comparative analysis of recombinant trypsin variants for enhanced MS-based peptide identification and quantification
New Technology: Sample Preparation
Di., 22.10.
15:27 – 15:39 10 Min. 2 Min.
Oral presentation
OP-53
Combining Proteome Integral Solubility Alteration (PISA) assay and one-tip workflow for a streamlined and high-throughput drug target deconvolution
New Technology: Sample Preparation
Mi., 23.10.
Poster presentation
P-III-0990
Proteomic strategy to identify the cell-surface progesterone-receptor mediating nongenomic steroid-signaling in human sperm cells
Cell Biology Insights